LOGO
ȸ»ç¼Ò°³
ȸ»ç¼Ò°³
KR ¹ÙÀÌ·¯½º ¾ÈÀü¼º ½ÃÇè Æò°¡¿ø
KR ¹ÙÀÌ·¯½º ¾ÈÀü¼º ½ÃÇè Æò°¡¿ø
¿¬±¸ºÐ¾ß
¿¬±¸ºÐ¾ß
Á¦Ç°¼Ò°³
Á¦Ç°¼Ò°³
Á¤º¸
Á¤º¸
Contact
Contact
ENG
KOR
≡
X
Àλ縻
ȸ»ç¿¬Çõ
KR ¹ÙÀÌ·¯½º ¾ÈÀü¼º ½ÃÇè Æò°¡¿ø
¹ÙÀÌ·¯½º ºÒÈ°È ½ÃÇè
¿Ü·¡¼º ¿À¿° ÀÎÀÚ ½ÃÇè
Ç×¹ÙÀÌ·¯½º Á¦Á¦ È¿´É Æò°¡
¹ÙÀÌ·¯½º »ç¸ê È¿´É Æò°¡
¹é½Å°³¹ß
Ç×¹ÙÀÌ·¯½ºÁ¦ °³¹ß
õ¿¬¹° ¼Òµ¶Á¦ ¿¬±¸
À¯ÀüÀÚ Ä¡·áÁ¦ °³¹ß
ƯÇã
³í¹®
±â´É¼ºÈÀåÇ°
News&Notices
1:1¹®ÀÇ
ã¾Æ¿À½Ã´Â ±æ
KR
EN
ȸ»ç¼Ò°³
Àλ縻
ȸ»ç¿¬Çõ
KR¹ÙÀÌ·¯½º ¾ÈÀü¼º ½ÃÇè Æò°¡¿ø
KR ¹ÙÀÌ·¯½º ¾ÈÀü¼º ½ÃÇè Æò°¡¿ø ¼Ò°³
¹ÙÀÌ·¯½º ºÒÈ°È ½ÃÇè
¿Ü·¡¼º ¿À¿° ÀÎÀÚ ½ÃÇè
Ç×¹ÙÀÌ·¯½º Á¦Á¦ È¿´É Æò°¡
¹ÙÀÌ·¯½º »ç¸ê È¿´É Æò°¡
¿¬±¸ºÐ¾ß
¹é½Å°³¹ß
Ç×¹ÙÀÌ·¯½ºÁ¦ °³¹ß
õ¿¬¹° ¼Òµ¶Á¦ ¿¬±¸
À¯ÀüÀÚ Ä¡·áÁ¦ °³¹ß
³í¹®
ƯÇã
Á¦Ç°¼Ò°³
±â´É¼ºÈÀåÇ°
Á¤º¸
News&Notices
Contact
1:1 »ó´ã¹®ÀÇ
ã¾Æ¿À½Ã´Â ±æ
¿¬±¸ºÐ¾ß
³í¹®
¿¬±¸ºÐ¾ß
ȸ»ç¼Ò°³
KR ¹ÙÀÌ·¯½º ¾ÈÀü¼º ½ÃÇè Æò°¡¿ø
¿¬±¸ºÐ¾ß
Á¦Ç°¼Ò°³
Á¤º¸
Contact
³í¹®
¹é½Å°³¹ß
Ç×¹ÙÀÌ·¯½ºÁ¦ °³¹ß
õ¿¬¹° ¼Òµ¶Á¦ ¿¬±¸
À¯ÀüÀÚ Ä¡·áÁ¦ °³¹ß
ƯÇã
³í¹®
Total :
1
Subject
Contents
Subject + Contents
Writer
ID
Search
No.
Subject
Writer
Date
Hits
8
Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein
KR BIOTECH
2016-10-28
1563
7
±¹³» µÅÁö¿¡ Á¸ÀçÇÏ´Â ³»¼º ·¹Æ®·Î ¹ÙÀÌ·¯½ºÀÇ ºÐÆ÷
KR BIOTECH
2016-10-28
1560
6
Monophyletic Clade of HIV-1 Subtype B in Korea: Evolutionary Pressure or Single Introduction?
KR BIOTECH
2016-10-28
1647
5
Natural Polymorphisms of Protease in Protease Inhibitor-Naive HIV-1 Infected Patients in Korea: A no
KR BIOTECH
2016-10-28
1603
4
Control of viremia and prevention of SHIV-induced disease in rhesus macaques immunized with inactiva
KR BIOTECH
2016-10-28
1605
3
Immunogenicity and ability of variable loop-deleted HIV-1 envelope glycoproteins to elicit neutraliz
KR BIOTECH
2016-10-28
1671
2
Development of a Safe and Rapid Neutralization Assay Using Murine Leukemia Virus Pseudotyped with HI
KR BIOTECH
2016-10-28
1683
1
Polyvalent Envelope Glycoprotein Vaccine Elicits a Broader Neutralizing Antibody Response but Is Una
KR BIOTECH
2016-10-28
1573
6
/